Published on 26 Nov 2022 on Zacks via Yahoo Finance
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
Clovis Oncology, Inc.’s CLVS shares have plunged 49.6% in the past six months against the industry’s 3% rise.
Image Source: Zacks Investment Research
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session...
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Boulder drugmaker Clovis Oncology files for bankruptcy - Denver Business Journal
The public company reported that its assets were about $320 million, while its estimated liabilit...
Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
Clovis Oncology, Inc. CLVS announced that the company and some of its subsidiaries initiated volu...
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
Clovis Oncology, maker of ovarian cancer drug Rubraca, has filed for chapter 11 and proposed sell...
Clovis Plans to Sell Cancer Drug to Novartis in Bankruptcy Deal
(Bloomberg) -- Clovis Oncology Inc. filed for bankruptcy and plans to sell its experimental cance...
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
Clovis Oncology, Inc.’s CLVS shares have plunged 49.6% in the past six months against the industr...
Clovis (CLVS) Plummets on News of Possible Bankruptcy Filing
Shares of Clovis Oncology CLVS plunged 71.6% after the company announced that it will not have su...
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95% By Investing.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95%
Clovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue Estimates
Clovis Oncology (CLVS) came out with a quarterly loss of $0.39 per share versus the Zacks Consens...
Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023
Clovis Oncology Inc. shares plunged 75% Wednesday, after the Colorado-based biotech said it will ...